Adaptive Biotechnologies Corporation
ADPT
$7.94
$0.2152.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.05% | 30.62% | 2.70% | 31.59% | -38.05% |
| Total Depreciation and Amortization | -3.11% | -8.24% | -4.05% | -3.30% | -6.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.92% | -36.26% | 48.04% | -64.94% | 146.27% |
| Change in Net Operating Assets | 123.44% | -560.97% | 127.42% | -193.45% | 81.16% |
| Cash from Operations | 53.85% | -56.42% | 54.88% | -42.41% | 42.31% |
| Capital Expenditure | 76.74% | 80.10% | -14.43% | -16.41% | 53.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 294.23% | -25.97% | -83.47% | 921.53% | -84.42% |
| Cash from Investing | 318.37% | -10.04% | -86.80% | 1,287.87% | -87.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 217.50% | 33.33% | -31.82% | -49.43% | 411.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 217.50% | 33.33% | -31.82% | -49.43% | 411.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.88% | -90.75% | -283.81% | 126.23% | -15.14% |
